Pzena Investment Management LLC Lowers Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Pzena Investment Management LLC lowered its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 10.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,302,780 shares of the company's stock after selling 158,020 shares during the period. Pzena Investment Management LLC owned 3.22% of Phibro Animal Health worth $27,358,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of PAHC. Thrivent Financial for Lutherans raised its position in shares of Phibro Animal Health by 23.1% during the third quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company's stock valued at $468,000 after buying an additional 3,907 shares during the last quarter. Segall Bryant & Hamill LLC raised its position in shares of Phibro Animal Health by 1.7% during the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company's stock valued at $3,931,000 after buying an additional 2,971 shares during the last quarter. Algert Global LLC raised its position in shares of Phibro Animal Health by 521.1% during the third quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after buying an additional 59,850 shares during the last quarter. FMR LLC raised its position in shares of Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company's stock valued at $885,000 after buying an additional 7,270 shares during the last quarter. Finally, Quantbot Technologies LP bought a new stake in shares of Phibro Animal Health during the third quarter valued at approximately $70,000. Institutional investors own 99.34% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on PAHC shares. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. StockNews.com cut shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Friday, March 7th. Finally, Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $21.00.

Phibro Animal Health Price Performance

PAHC traded up $0.76 during trading hours on Friday, hitting $21.25. The company's stock had a trading volume of 335,608 shares, compared to its average volume of 260,563. The business's 50-day moving average price is $22.56 and its 200-day moving average price is $22.56. Phibro Animal Health Co. has a 12 month low of $12.05 and a 12 month high of $26.55. The stock has a market cap of $860.69 million, a price-to-earnings ratio of 44.27, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Sell-side analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is currently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.